Order Article Reprints

Lobo J, Cardoso AR, Miranda-Gonçalves V, Looijenga LHJ, Lopez M, Arimondo PB, Henrique R, Jerónimo C. Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics. 2021; 13(1):73. https://doi.org/10.3390/pharmaceutics13010073

Lobo, João, Ana Rita Cardoso, Vera Miranda-Gonçalves, Leendert H. J. Looijenga, Marie Lopez, Paola B. Arimondo, Rui Henrique, and Carmen Jerónimo. 2021. "Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest" Pharmaceutics 13, no. 1: 73. https://doi.org/10.3390/pharmaceutics13010073

Lobo, J., Cardoso, A. R., Miranda-Gonçalves, V., Looijenga, L. H. J., Lopez, M., Arimondo, P. B., Henrique, R., & Jerónimo, C. (2021). Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics, 13(1), 73. https://doi.org/10.3390/pharmaceutics13010073